And they keep this business going by ongoing studies, payments, shifting of drugs designed for one purpose into a different purpose (see Ampyra) ... make no mistake, MS is a business. - and until the status quo changes (be it CCSVI, or some other theory that proves out) business is GOOD. Neurologists are not questioning the CRABs drugs, because it is ALL they have that has shown ANY benefit (no ma